Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1343169 | 0.85 | DYRK1A (0.42) | DYRK1ATSHRLMNAALDH1A1MAPT | |
| SCHEMBL20911599 | 0.85 | DYRK1A (0.38) | DYRK1ASMN1; SMN2HIF1ATSHRLMNA | |
| SCHEMBL16953469 | 0.85 | DYRK1A (0.38) | DYRK1ASMN1; SMN2HIF1ATSHRLMNA | |
| SCHEMBL645262 | 0.82 | TSHR (0.48) | SMN1; SMN2HIF1ATSHRCA1CA2 | |
| SCHEMBL28295603 | 0.78 | TDP1 (0.39) | DYRK1ASMN1; SMN2HIF1ATSHRALDH1A1 | |
| SCHEMBL31032883 | 0.78 | DYRK1A (0.47) | DYRK1ATSHRLMNACA1CA2 | |
| SCHEMBL3386194 | 0.78 | DYRK1A (0.47) | DYRK1ATSHRLMNACA1CA2 | |
| SCHEMBL136719 | 0.77 | — | — | |
| SCHEMBL30201156 | 0.77 | — | — | |
| SCHEMBL17818517 | 0.77 | TSHR (0.50) | DYRK1ATSHRLMNACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119330339-A | Method for preparing porous carbon based on synchronous synthesis of nitrile resin/graphene nanosheets and porous carbon material | 成都大学 | 2025-01-21 | — | — | CN | claimed |
| CN-111875794-A | Novel preparation method of nitrile resin monomer | 成都大学 | 2020-11-03 | — | — | CN | claimed |
| CN-119330339-A | Method for preparing porous carbon based on synchronous synthesis of nitrile resin/graphene nanosheets and porous carbon material | 成都大学 | 2025-01-21 | — | — | CN | disclosed |
| WO-2023136136-A1 | COMPOUND AND COLORED RESIN COMPOSITION | 住友化学株式会社 | 2023-07-20 | — | — | WO | disclosed |
| CN-116082231-A | Rapid preparation method and application of 3-aminoquinoline derivative | 精华制药集团南通有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-114890963-B | Benzylidene thiazolidinedione derivative, and preparation method and application thereof | 湖州师范学院 | 2023-05-05 | — | — | CN | disclosed |
| CN-108148055-B | D-pi-A type organic fluorescent material based on naphthalene and preparation method thereof | 陕西师范大学 | 2021-04-13 | — | — | CN | disclosed |
| CN-111875794-A | Novel preparation method of nitrile resin monomer | 成都大学 | 2020-11-03 | — | — | CN | disclosed |
| US-20120068123-A1 | USE OF PHTHALOCYANINE COMPOUNDS WITH ARYL OR HETARYL SUBSTITUENTS IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2012-03-22 | — | — | US | disclosed |
| US-7442696-B2 | Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses | LIGAND PHARMACEUTICALS, INC. (US) | 2008-10-28 | — | — | US | disclosed |
| US-20070197520-A1 | MINERALOCORTICOID RECEPTOR MODULATOR COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USES | LIGAND PHARMACEUTICALS INC. | 2007-08-23 | — | — | US | disclosed |
| WO-2006010142-A2 | MINERALOCORTICOID RECEPTOR MODULATOR COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE | LIGAND PHARMACEUTICALS, INC. (US) | 2006-01-26 | — | — | WO | disclosed |
| US-5776576-A | Phthalaocyanine compound as a layer in optical recording medium | Shirai, Hirofusa (JP) | 1998-07-07 | — | — | US | disclosed |
| US-5618930-A | PHTHALOCYANINE COMPOUNDS HAVING IMPROVED SOLUBILITY AND HIGH PURITY | Shirai, Hirofusa (JP) | 1997-04-08 | — | — | US | disclosed |
| US-5516900-A | IMPROVED SOLUBILITY AND PURITY | Shirai, Hirofusa (JP) | 1996-05-14 | — | — | US | disclosed |
| US-5262052-A | Separation of polycyclic aromatic hydrocarbons | BRIGHAM YOUNG UNIVERSITY (US) | 1993-11-16 | — | — | US | disclosed |
| US-4239686-A | Process for producing phthalimido derivatives | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120068123-A1 | USE OF PHTHALOCYANINE COMPOUNDS WITH ARYL OR HETARYL SUBSTITUENTS IN ORGANIC SOLAR CELLS | RB1, NRAS, HLA-B | DYRK1A 2265/4885SMN1; SMN2 4626/4885HIF1A 4417/4885 |
| US-20070197520-A1 | MINERALOCORTICOID RECEPTOR MODULATOR COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USES | NR3C2, MC2R, NR3C1 | DYRK1A 2150/4885SMN1; SMN2 4862/4885HIF1A 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.